Fei Xue

机构：Qingdao University of Science and Technology, China Three Gorges University, Zhangjiakou Academy of Agricultural Sciences, Qilu Hospital of Shandong University, State Key Laboratory for Innovation and Transformation of Luobing Theory, Qingdao University of Technology · ORCID：0000-0001-7047-8497

发表论文 132 篇 · 总被引 3615 次 · h-index 30

代表论文

Cardiomyocyte-specific knockout of ADAM17 ameliorates left ventricular remodeling and function in diabetic cardiomyopathy of mice (2022 · Signal Transduction and Targeted Therapy · 被引 122)
NPRC deletion attenuates cardiac fibrosis in diabetic mice by activating PKA/PKG and inhibiting TGF-β1/Smad pathways (2023 · Science Advances · 被引 81)
Associations of different insulin resistance-related indices with the incidence and progression trajectory of cardiometabolic multimorbidity: a prospective cohort study from UK biobank (2025 · Cardiovascular Diabetology · 被引 75)
Association between the triglyceride-glucose index and impaired cardiovascular fitness in non-diabetic young population (2024 · Cardiovascular Diabetology · 被引 55)
Cardiomyocyte-specific knockout of ADAM17 alleviates doxorubicin-induced cardiomyopathy via inhibiting TNFα–TRAF3–TAK1–MAPK axis (2024 · Signal Transduction and Targeted Therapy · 被引 40)
ADAM17 knockdown mitigates while ADAM17 overexpression aggravates cardiac fibrosis and dysfunction via regulating ACE2 shedding and myofibroblast transformation (2022 · Frontiers in Pharmacology · 被引 24)